Research Topics
| M DuongSummaryAffiliation: CHU de Dijon Country: France Publications
| Collaborators
|
Detail Information
Publications
Concentration of circulating oxidized LDL in HIV-infected patients treated with antiretroviral agents: relation to HIV-related lipodystrophyMichel Duong
Division of Infectious Diseases, University Hospital, Dijon, France
HIV Clin Trials 7:41-7. 2006..The aim of the study was to investigate the concentrations of ox-LDL in HIV-infected patients under antiretroviral therapy with (HIV-LD) or without (HIV-nLD) HIV-related lipodystrophy...- Usefulness of therapeutic drug monitoring of antiretrovirals in routine clinical practiceMichel Duong
Division of Infectious Diseases, University Hospital, Dijon, France
HIV Clin Trials 5:216-23. 2004..Clinical trials have shown that therapeutic drug monitoring (TDM) of antiretrovirals (ARV) improves patient care. However, little is known about the usefulness of TDM in routine practice... - Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviral therapyM Duong
Division of Infectious Diseases, Department of Endocrinology, and Division of Hepatology, University Hospital, Dijon, France
J Acquir Immune Defic Syndr 27:245-50. 2001..Our findings suggest that chronic HCV infection is a significant factor associated with the development of metabolic abnormalities and with modifications in body composition in HIV patients receiving antiretroviral treatment... - [Vaccination coverage of healthcare professionals in an infectious diseases department]M Duong
Département d infectiologie, Hopital du Bocage, CHU, Boulevard Marechal De Lattre de Tassigny, 21000 Dijon, France
Med Mal Infect 41:135-9. 2011..The study's objective was to evaluate with a standardized questionnaire the knowledge of healthcare workers (HCWs) regarding occupational vaccinations and their vaccination coverage... - Limitation of exercise capacity in nucleoside-treated HIV-infected patients with hyperlactataemiaM Duong
Service des Maladies Infectieuses, Hopital Universitaire du Bocage, Dijon, France
HIV Med 8:105-11. 2007..Hyperlactataemia, which is a consequence of a shift in the metabolism of pyruvate, is an indicator of nucleoside-related mitochondrial toxicity... - Low trough plasma concentrations of nevirapine associated with virologic rebounds in HIV-infected patients who switched from protease inhibitorsMichel Duong
Department of Infectious Diseases, Hopital du Bocage, Dijon, France
Ann Pharmacother 39:603-9. 2005..However, the switch from PIs to an NNRTI could fail for a number of reasons, including NNRTI-associated toxicity and emergence of NNRTI-resistant variants... - Exercise stress testing for detection of silent myocardial ischemia in human immunodeficiency virus-infected patients receiving antiretroviral therapyM Duong
Service des Maladies Infectieuses, Hopital du Bocage, Dijon 21034, France
Clin Infect Dis 34:523-8. 2002..Exercise testing might be recommended for patients with HIV who have central fat accumulation and hypercholesterolemia... - HIV-1 protease inhibitors induce an increase of triglyceride level in HIV-infected men without modification of insulin sensitivity: a longitudinal studyJ M Petit
Service d'Endocrinologie, , Dijon, France
Horm Metab Res 32:367-72. 2000..These results suggest that PI could be responsible for the development of hypertriglyceridemia by a mechanism independent of insulin resistance which remains to be elucidated... - Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: relationship to virologic responseM Duong
Division of Infectious Diseases, University Hospital, Dijon, 21034, France
Clin Infect Dis 33:386-92. 2001..006). PI level was the higher significant predictor of virologic response (P=.0003). Self-reported adherence (P=.01) and macrocytosis (P=.05) were also independently associated with antiretroviral efficacy... - [Is there an increased risk for cardiovascular disease in HIV-infected patients on antiretroviral therapy?]M Duong
Service des Maladies Infectieuses, , 21034 Dijon, France
Ann Cardiol Angeiol (Paris) 52:302-7. 2003..Despite these uncertainties, it seems reasonable to identify and manage cardiovascular risk factors in HIV infected patients... - Coronary heart disease associated with the use of human immunodeficiency virus (HIV)-1 protease inhibitors: report of four cases and reviewM Duong
Service des Maladies Infectieuses, Centre Hospitalo-Universitaire de Dijon, Hopital du Bocage, France
Clin Cardiol 24:690-4. 2001..Evaluation and control of risk factors for CHD should be performed in each patient for whom treatment with a PI is indicated... - Incidence of gynecomastia in men infected with HIV and treated with highly active antiretroviral therapyL Piroth
Department of Infectious Diseases, University Hospital of Dijon, France
Scand J Infect Dis 33:559-60. 2001..8/100 patient-years, with a prevalence of 2.8% in those treated for > or = 2 y. Even though the physiopathology remains unclear, this study suggests that gynecomastia should be monitored in these patients... - Evaluation of the Patient Medication Adherence Questionnaire as a tool for self-reported adherence assessment in HIV-infected patients on antiretroviral regimensM Duong
Division of Infectious Diseases, University Hospital, Dijon, France
HIV Clin Trials 2:128-35. 2001..To improve the feasibility and the reproducibility of the PMAQ, we propose a revised form of the PMAQ, focusing on the variables identified as strong predictors of adherence... - Serum adiponectin and metabolic parameters in HIV-1-infected patients after substitution of nevirapine for protease inhibitorsJ M Petit
Hopital Universitaire du Bocage, Dijon, France
Eur J Clin Invest 34:569-75. 2004..The aim of the present study was to examine whether adiponectin concentration or insulin sensitivity level correlate with the modifications of lipid parameters after the switch of PI by nevirapine... - [Measure of effectiveness and adherence to antiretroviral therapy in HIV-infected patients in Cameroon]S Mahy
Département d infectiologie, Hôpital d Enfants, CHU de Dijon, Boulevard Marechal De Lattre de Tassigny, Dijon, France
Med Mal Infect 41:176-80. 2011..The aim of the study was to identify the most useful clinical criteria to measure effectiveness and adherence to antiretroviral treatment in a rural area of Cameroon... - [Factors influencing the prescription or non-prescription of antibiotics by general practitioners]H Faure
Département d infectiologie, CHU de Dijon, 21079 Dijon Cedex, France
Med Mal Infect 39:714-21. 2009.... - [Recurrent non tuberculous mycobacterial infections: think about anti-interferon-gamma autoantibodies!]J B Picque
Département d infectiologie, CHU de Dijon, 2, Boulevard du Maréchal de Lattre de Tassigny, 21079 Dijon Cedex, France
Rev Med Interne 33:103-6. 2012..They have been mainly reported in AIDS patients. Cases related to the presence of anti-interferon-? autoantibodies are rare... - LDL-receptors expression in HIV-infected patients: relations to antiretroviral therapy, hormonal status, and presence of lipodystrophyJ M Petit
Hopital Universitaire du Bocage, 21000 Dijon, France
Eur J Clin Invest 32:354-9. 2002..Moreover, HIV infection and HAART are associated with important modifications of hormonal status. As the cause of these adverse reactions is unknown, the effects of HAART and lipodystrophy on LDL receptors were evaluated... - Clinical, immunological and virological evolution in patients with CD4 T-cell count above 500/mm3: is there a benefit to treat with highly active antiretroviral therapy (HAART)?Lionel Piroth
Service des Maladies, Infectieuses et Tropicales, Hôpital d Enfants, CHU Dijon, France
Eur J Epidemiol 19:597-604. 2004..However, the CD4 decay slope after 3 years, the risk of therapeutic side-effects and the low risk of clinical progression do not support systematic treatment of those patients... - Increased VLDL-apoB and IDL-apoB production rates in nonlipodystrophic HIV-infected patients on a protease inhibitor-containing regimen: a stable isotope kinetic studyJean Michel Petit
Laboratoire de Biochimie and Institut National de la Santé et de la Recherche Médicale U498, Hopital Universitaire du Bocage, 21000 Dijon, France
J Lipid Res 44:1692-7. 2003..These data confirm that PI therapy is associated with a physiopathological mechanism for dyslipidemia in addition to the effect of lipodystrophy on lipid metabolism... - Emergence of tularemia in France: paradigm of the Burgundy regionS Mahy
Centre Hospitalier Universitaire de Dijon, Universite de Bourgogne, Dijon, France
Int J Infect Dis 15:e882-3. 2011..These cases highlight the increased incidence and geographical spread of tularemia in France, and the usefulness of real-time PCR technology for the early diagnostic confirmation of tularemia... - Relationship between levels of indinavir in hair and virologic response to highly active antiretroviral therapyLouis Bernard
Division of Infectious Diseases, Geneva University Hospital and Laboratoire de Virologie, Rue Micheli du Crest, CH 1211 Geneva, Switzerland
Ann Intern Med 137:656-9. 2002..Suboptimal levels of antiretroviral drugs result in virologic failure in HIV-infected patients treated with highly active antiretroviral therapy (HAART)... - Acute liver enzyme elevations in HIV-1-infected patientsClaire Livry
, , CHU Dijon, France
HIV Clin Trials 4:400-10. 2003..These patient-linked variables must be taken into account to avoid unwarranted treatment withdrawal... - The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patientsLionel Piroth
Infectious Diseases Department, Service des Maladies Infectieuses et Tropicales, , 21034 Dijon Cedex, France
J Hepatol 36:681-6. 2002..Isolated anti-HBc pattern must be considered in the management of hepatitis C, but not for antiretroviral therapy...